Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
15 August 2022 |
Main ID: |
NCT02656017 |
Date of registration:
|
23/12/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
TAME |
Scientific title:
|
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease |
Date of first enrolment:
|
June 27, 2016 |
Target sample size:
|
97 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02656017 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
Phase:
|
Phase 2
|
|
Countries of recruitment
|
United States
| | | | | | | |
Contacts
|
Name:
|
Kyongtae Bae, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University of Pittsburgh |
| | |
Key inclusion & exclusion criteria
|
Health Condition(s) or Problem(s) studied
|
Source(s) of Monetary Support
|
|